Article Text

Download PDFPDF
The influence of the pharmaceutical industry on the off-label use of its medicines
  1. D O E Gebhardt
  1. Anna van Burenlaan 1, 2341 VE Oegstgeest, The Netherlands; doe.gebhardt@planet.nl

    Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Last year I described in this journal1 an unacceptable influence of a pharmaceutical company on the off-label use of one of its products. Now I would like to report on an acceptable and even praiseworthy initiative of a pharmaceutical manufacturer in monitoring the use of its drug. The devastating action of thalidomide on the human embryo caused its withdrawal from the market in …

    View Full Text